James M. O’Donnell

6.6k total citations
157 papers, 5.3k citations indexed

About

James M. O’Donnell is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, James M. O’Donnell has authored 157 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 50 papers in Pharmacology and 40 papers in Cellular and Molecular Neuroscience. Recurrent topics in James M. O’Donnell's work include Receptor Mechanisms and Signaling (63 papers), Phosphodiesterase function and regulation (63 papers) and Cholinesterase and Neurodegenerative Diseases (44 papers). James M. O’Donnell is often cited by papers focused on Receptor Mechanisms and Signaling (63 papers), Phosphodiesterase function and regulation (63 papers) and Cholinesterase and Neurodegenerative Diseases (44 papers). James M. O’Donnell collaborates with scholars based in United States, China and Ireland. James M. O’Donnell's co-authors include Han‐Ting Zhang, Klaus A. Miczek, Ying Huang, Lewis S. Seiden, Ying Xu, Yunfeng Li, Anbrin Masood, Ahmed Nadeem, Lan Xiao and Marco Conti and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Scientific Reports.

In The Last Decade

James M. O’Donnell

155 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James M. O’Donnell United States 43 2.9k 1.6k 1.5k 797 606 157 5.3k
Luca Steardo Italy 42 1.3k 0.5× 2.0k 1.2× 1.8k 1.2× 993 1.2× 365 0.6× 137 5.8k
J. Javier Meana Spain 41 2.9k 1.0× 1.1k 0.7× 3.6k 2.4× 677 0.8× 558 0.9× 243 6.3k
Małgorzata Filip Poland 46 3.4k 1.1× 1.2k 0.7× 4.5k 3.0× 809 1.0× 428 0.7× 264 7.6k
Yousef Tizabi United States 41 2.0k 0.7× 656 0.4× 2.3k 1.5× 1.1k 1.3× 724 1.2× 179 5.3k
Christian P. Müller Germany 44 2.4k 0.8× 654 0.4× 2.5k 1.6× 777 1.0× 494 0.8× 201 6.9k
Grażyna Biała Poland 30 1.6k 0.5× 828 0.5× 1.8k 1.2× 725 0.9× 323 0.5× 117 4.2k
Robert H. Lipsky United States 44 2.6k 0.9× 709 0.4× 2.5k 1.6× 743 0.9× 557 0.9× 112 8.1k
Bruno P. Guiard France 36 1.8k 0.6× 858 0.5× 2.7k 1.8× 834 1.0× 1.0k 1.7× 97 5.5k
Yann S. Mineur United States 37 2.7k 0.9× 627 0.4× 2.0k 1.3× 889 1.1× 835 1.4× 78 5.9k
Lee E. Schechter United States 42 2.3k 0.8× 672 0.4× 2.6k 1.7× 353 0.4× 523 0.9× 95 5.3k

Countries citing papers authored by James M. O’Donnell

Since Specialization
Citations

This map shows the geographic impact of James M. O’Donnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. O’Donnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. O’Donnell more than expected).

Fields of papers citing papers by James M. O’Donnell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. O’Donnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. O’Donnell. The network helps show where James M. O’Donnell may publish in the future.

Co-authorship network of co-authors of James M. O’Donnell

This figure shows the co-authorship network connecting the top 25 collaborators of James M. O’Donnell. A scholar is included among the top collaborators of James M. O’Donnell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. O’Donnell. James M. O’Donnell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ling, Chen, Su‐Ying Cui, Haiyang Yu, et al.. (2019). Reduced phosphodiesterase-2 activity in the amygdala results in anxiolytic-like effects on behavior in mice. Journal of Psychopharmacology. 33(5). 568–576. 8 indexed citations
3.
Cui, Su‐Ying, Yonghe Zhang, Victor Zheng, et al.. (2019). Protection from Amyloid β Peptide–Induced Memory, Biochemical, and Morphological Deficits by a Phosphodiesterase-4D Allosteric Inhibitor. Journal of Pharmacology and Experimental Therapeutics. 371(2). 250–259. 28 indexed citations
4.
Liu, Li, Xianfeng Huang, Xia Zhu, et al.. (2018). The neuroprotective and antidepressant‐like effects of Hcyb1, a novel selective PDE2 inhibitor. CNS Neuroscience & Therapeutics. 24(7). 652–660. 19 indexed citations
5.
Zhang, Chong, Lindsay M. Lueptow, Han‐Ting Zhang, James M. O’Donnell, & Ying Xu. (2017). The Role of Phosphodiesterase-2 in Psychiatric and Neurodegenerative Disorders. Advances in neurobiology. 17. 307–347. 26 indexed citations
6.
Zhang, Chong, Lina Ruan, Chuang Wang, et al.. (2014). The Roles of Phosphodiesterase 2 in the Central Nervous and Peripheral Systems. Current Pharmaceutical Design. 21(3). 274–290. 29 indexed citations
7.
Sluka, Kathleen A., Lynn Rasmussen, James M. O’Donnell, et al.. (2013). Acid‐Sensing Ion Channel 3 Deficiency Increases Inflammation but Decreases Pain Behavior in Murine Arthritis. Arthritis & Rheumatism. 65(5). 1194–1202. 43 indexed citations
8.
Fil, Daniel, et al.. (2009). Phosphodiesterase 4B2 gene is an effector of Toll-like receptor signaling in astrocytes. Metabolic Brain Disease. 24(3). 481–491. 6 indexed citations
9.
O’Donnell, James M., et al.. (2004). Social Justice in These Times. 21 indexed citations
10.
O’Donnell, James M., et al.. (2002). Effects of Antidepressants in Rats Trained to Discriminate Centrally Administered Isoproterenol. Journal of Pharmacology and Experimental Therapeutics. 302(2). 606–611. 16 indexed citations
11.
Makhay, Malath, et al.. (2001). Discriminative stimulus effects of centrally administered isoproterenol in rats: mediation by beta-1 adrenergic receptors. Psychopharmacology. 154(1). 70–75. 22 indexed citations
12.
Makhay, Malath, Miles D. Houslay, & James M. O’Donnell. (2001). Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats. Psychopharmacology. 158(3). 297–304. 6 indexed citations
13.
Ye, Ying, et al.. (2000). Effects of Repeated Antidepressant Treatment on Type 4A Phosphodiesterase (PDE4A) in Rat Brain. Journal of Neurochemistry. 74(3). 1257–1262. 48 indexed citations
14.
O’Donnell, James M.. (1999). Behavioral Effects of Family-Selective Inhibitors of Cyclic Nucleotide Phosphodiesterases. Pharmacology Biochemistry and Behavior. 63(1). 185–192. 47 indexed citations
15.
O’Donnell, James M., et al.. (1995). Facilitation of norepinephrine release from cerebral cortex is mediated by β2-adrenergic receptors. Life Sciences. 57(20). PL327–PL332. 12 indexed citations
16.
O’Donnell, James M.. (1990). The development of a climate for caring: a historical review of premature care in the United States from 1900 to 1979.. PubMed. 8(6). 7–17. 7 indexed citations
17.
O’Donnell, James M.. (1990). Behavioral effects of beta adrenergic agonists and antidepressant drugs after down-regulation of beta-2 adrenergic receptors by clenbuterol.. Journal of Pharmacology and Experimental Therapeutics. 254(1). 147–157. 28 indexed citations
18.
O’Donnell, James M. & Alan Frazer. (1984). Effects of clenbuterol and tricyclic antidepressants on beta-adrenergic receptor/n-protein coupling in rat cerebral cortex. Federation Proceedings. 43(4). 1 indexed citations
19.
McCarthy, Colm, et al.. (1982). Effect of Cimetidine on Histamine-Activated ATPase in Human Gastric Mucosa. Digestion. 25(3). 173–179. 2 indexed citations
20.
O’Donnell, James M.. (1962). A case of sporotrichosis.. The Medical Journal of Australia. 1(14). 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Luca Steardo Breakdown of academic impact, for papers by J. Javier Meana Breakdown of academic impact, for papers by Małgorzata Filip Breakdown of academic impact, for papers by Yousef Tizabi Breakdown of academic impact, for papers by Christian P. Müller Breakdown of academic impact, for papers by Grażyna Biała Breakdown of academic impact, for papers by Robert H. Lipsky Breakdown of academic impact, for papers by Bruno P. Guiard Breakdown of academic impact, for papers by Yann S. Mineur Breakdown of academic impact, for papers by Lee E. Schechter
Rankless by CCL
2026